Intrinsiqq
Arcutis Biotherapeutics Inc. logo

Arcutis Biotherapeutics Inc.

ARQT

Compare
⚠ Showing the latest available close (Nov 9, 2026, 2 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$3.31B
EPS$0.22
P/E119.09
P/FCF55.49
EV/EBITDA84.68
FCF Yield1.8%
Div. Yield–
Net Debt/FCF-2.4x
Arcutis Biotherapeutics Inc. intrinsic value
52-Week Range
$19.50$34.05

Profitability & Returns

Revenue (TTM)

$509M

▲ +91.3% YoY

Net Income (TTM)

$30M

▲ +88.5% YoY

Op. Margin

6.91%

▲ +62.1pp YoY

ROIC

10.53%

▲ +32.7pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

$60M

▲ +94.4% YoY

Op. Cash Flow (TTM)

$60M

▲ +95.0% YoY

Net Debt

-$145M

Net Cash Position

Cash & Equiv.

$259M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with ARQT

CompareIntrinsic value
VREOFVireo Growth Inc.
$6.78+3.83%30
NATRNature's Sunshine Products Inc.
$11.02+1.38%68
HCMHUTCHMED (China) Ltd
$15.33+0.07%45
ARDXArdelyx Inc.
$2.93+1.74%40
CRMDCorMedix Inc.
$5.47+2.82%84
ORGOOrganogenesis Holdings Inc.
$0.91+11.57%50
LQDALiquidia Corporation
$50.71+5.93%63
ZLABZai Lab Ltd
$26.86+5.42%40

Held by ETFs

ARQT is in 60 US ETFs. The largest of them, with ARQT's weight in each:

Arcutis Biotherapeutics (ARQT) in four numbers

Fair value (earnings)
$1.10
Price $26.20 is 2285% above it.
Intrinsic Value
Quality score
65/100
Best check: revenue growth, 242.7%. Weakest: share count change, 148.6%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
119.09
Price to free cash flow 55.49.
Financials

Questions about Arcutis Biotherapeutics

Is Arcutis Biotherapeutics (ARQT) overvalued?

At $26.20, Arcutis Biotherapeutics' price is 2285% above the $1.10 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 119.09 times earnings and 55.49 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Arcutis Biotherapeutics' fair value?

Intrinsiqq's calculator puts Arcutis Biotherapeutics' fair value at $1.10 a share. It grows earnings per share 5% a year for 5 years, applies an exit P/E of 6.3, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $0.82. Every input can be changed on the Intrinsic Value tab.

Is Arcutis Biotherapeutics a high-quality business?

Arcutis Biotherapeutics scores 65 out of 100 on Intrinsiqq's quality score, which makes it a solid business on these measures. The score blends 7 checks computed from SEC filings. Its best check is revenue growth at 242.7%, and its weakest is share count change at 148.6%. The Quality tab shows every check against its target.

Does Arcutis Biotherapeutics (ARQT) pay a dividend?

No. Arcutis Biotherapeutics (ARQT) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 30 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 9 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in ARQT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ARQT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.